计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
B405327-20mg |
20mg |
现货 ![]() |
| |
B405327-100mg |
100mg |
现货 ![]() |
|
别名 | 布喹那,6-氟-2-(2'-氟-[1,1'-联苯]-4-基)-3-甲基喹啉-4-羧酸 |
---|---|
英文别名 | BCP06006 | brequinarum | EX-A1515 | 2-(2'-Fluoro-1,1'-biphenyl-4-yl)-6-fluoro-3-methyl-4-quinolinecarboxylic acid | 4-Quinolinecarboxylic acid, 6-fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl- | DTXSID00242165 | DUP785; Biphenquinate; BPQ | NCGC004807 |
规格或纯度 | Moligand™, ≥98%(HPLC) |
英文名称 | Brequinar (DUP785) |
储存温度 | -20°C储存 |
运输条件 | 超低温冰袋运输 |
作用类型 | 抑制剂 |
作用机制 | 二氢烟酸脱氢酶抑制剂 |
产品介绍 |
Product Describtion: Brequinar (DUP785, NSC 368390) is an inhibitor of dihydroorotate dehydrogenase (DHODH) with an IC50 of ∼20 nM in vitro. |
ALogP | 5.6 |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 504753694 |
---|---|
分子类型 | 小分子 |
IUPAC Name | 6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid |
INCHI | InChI=1S/C23H15F2NO2/c1-13-21(23(27)28)18-12-16(24)10-11-20(18)26-22(13)15-8-6-14(7-9-15)17-4-2-3-5-19(17)25/h2-12H,1H3,(H,27,28) |
InChi Key | PHEZJEYUWHETKO-UHFFFAOYSA-N |
Canonical SMILES | CC1=C(C2=C(C=CC(=C2)F)N=C1C3=CC=C(C=C3)C4=CC=CC=C4F)C(=O)O |
Isomeric SMILES | CC1=C(C2=C(C=CC(=C2)F)N=C1C3=CC=C(C=C3)C4=CC=CC=C4F)C(=O)O |
PubChem CID | 57030 |
分子量 | 375.37 |
Reaxy-Rn | 8354757 |
溶解性 | Insoluble in water and ethanol;37 mg/mL(98.57 mM) in DMSO |
---|---|
敏感性 | 对热敏感 |
熔点 | 317 °C |
分子量 | 375.400 g/mol |
XLogP3 | 5.600 |
氢键供体数Hydrogen Bond Donor Count | 1 |
氢键受体数Hydrogen Bond Acceptor Count | 5 |
可旋转键计数Rotatable Bond Count | 3 |
精确质量Exact Mass | 375.107 Da |
单同位素质量Monoisotopic Mass | 375.107 Da |
拓扑极表面积Topological Polar Surface Area | 50.200 Ų |
重原子数Heavy Atom Count | 28 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 551.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
Reaxy-Rn | 8354757 |
---|
Purity(HPLC) | 98-100(%) |
---|---|
NMR Spectrum 1H | Conforms to Structure |
LC-MS for identification | Conforms |
¥599.90
1. Peters GJ, Sharma SL, Laurensse E, Pinedo HM. (1987) Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).. Invest New Drugs, 5 (3): (235-44). [PMID:2822596] [10.1021/op500134e] |
2. Arteaga CL, Brown TD, Kuhn JG, Shen HS, O'Rourke TJ, Beougher K, Brentzel HJ, Von Hoff DD, Weiss GR. (1989) Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).. Cancer Res, 49 (16): (4648-53). [PMID:2743343] [10.1021/op500134e] |
3. Chen SF, Ruben RL, Dexter DL. (1986) Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.. Cancer Res, 46 (10): (5014-9). [PMID:3019518] [10.1021/op500134e] |